The added value of a platform approach: pen injector case study
June 7, 2021Read moreThe latest issue of ‘Injectable Drug Delivery’ is highlighted our experts discussion about developing Nemera’s pen-injector platform to reach customer needs
Integrated turnkey solutions: key to successful nasal combination product development
June 4, 2021Read moreThe latest issue of ‘Nasal & Pulmonary Drug Delivery’ is highlighted our experts discussion about developing complex nasal devices helped by Nemera experience.
Patient Journey as a key to develop Inhalation combination products
May 12, 2021Read moreThe latest issue of ‘Pharma Technology’ is highlighted our experts point of view about developing adapted inhalation device for a better patient’s adherence.
Nemera is excited to announce that its multidose eye dropper Novelia® has been approved in Brazil!
May 5, 2021Read moreNovelia, Nemera’s preservative-free multi-dose eyedropper approved in Brazil for Aché’s NSAID’s and Dry Eye formulations
The pivotal role played by device developers to improve patient eye care
April 22, 2021Read moreThe latest issue of ‘Ophthalmic Drug Delivery’ is highlighted our experts discussion about the challenges of glaucoma and dry eyes patient face with eye drop administration.
